{"id":"W4407699539","doi":"10.1200/jco.2025.43.5_suppl.662","title":"A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with <i>FGFR3</i> alterations: Initial results from FORAGER-1.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Eli Lilly and Company","keywords":"Medicine; Gene isoform; Cancer research; Internal medicine; Pathology; Oncology; Biochemistry; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001994628,0.000276839,0.001403049,0.0004420491,0.00008566501,0.00002388182,0.0004934481,0.0004425702,0.000009954762],"category_scores_gemma":[0.003351867,0.0002254608,0.0002516473,0.0004951399,0.0002635824,0.00004788117,0.0002303191,0.001181506,0.000001694513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000174302,"about_ca_system_score_gemma":0.001767819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002526313,"about_ca_topic_score_gemma":0.005556593,"domain_scores_codex":[0.9941922,0.0008558339,0.00348651,0.0005642747,0.000439104,0.0004620298],"domain_scores_gemma":[0.9960914,0.001029983,0.001605656,0.0004066183,0.0006583178,0.0002079829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3227811,0.08569128,0.1386093,0.0002817571,0.002991711,0.004300825,0.00430386,0.01332173,0.3769608,0.0002050278,0.01017356,0.04037911],"study_design_scores_gemma":[0.268566,0.3078034,0.2341595,0.001766157,0.0003826784,0.0001223555,0.003672933,0.001134467,0.169256,0.002108332,0.009838081,0.00119011],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967901,0.0001242324,0.0003083698,0.0008609749,0.0003352481,0.0007834811,0.00007029519,0.000005251848,0.0007220252],"genre_scores_gemma":[0.9981003,0.00007840123,0.0008778601,0.0002849615,0.0004616975,0.00004276622,0.000044132,0.00002630589,0.00008361045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2221121,"threshold_uncertainty_score":0.9194025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04495718704566696,"score_gpt":0.4567314972121554,"score_spread":0.4117743101664884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}